87 results match your criteria: "Kobe City Eye Hospital[Affiliation]"

Robotic cell processing facility for clinical research of retinal cell therapy.

SLAS Technol

December 2023

Kobe City Eye Hospital. 2-1-8 Minatojima Minamimachi, Chuo-ku, Kobe, Hyogo, 650-0047 Japan; Robotic Biology Institute Inc. Telecom Center Building East Wing 1F, 2-5-10 Aomi, Koto-ku, Tokyo 135-0064 Japan; Laboratory for Biologically Inspired Computing, RIKEN Center for Biosystems Dynamics Research. 6-2-3 Furuedai, Suita, Osaka 565-0874 Japan; Vision Care Inc. Kobe Eye Center Building 5F, 2-1-8 Minatojima Minamimachi, Chuo-ku, Kobe, Hyogo 650-0047 Japan. Electronic address:

The consistent production of high-quality cells in cell therapy highlights the potential of automated manufacturing. Humanoid robots are a useful option for transferring technology to automate human cell cultures. This study evaluated a robotic cell-processing facility (R-CPF) for clinical research on retinal cell therapy, incorporating the versatile humanoid robot Maholo LabDroid and an All-in-One CP unit.

View Article and Find Full Text PDF

Regional developers' community accelerates laboratory automation.

SLAS Technol

December 2024

Laboratory Automation Suppliers' Association, 2-1-8 Minatojima Minamimachi, Chuo-ku, Kobe, Hyogo 650-0047 Japan; Laboratory for Biologically Inspired Computing, RIKEN Center for Biosystems Dynamics Research, 6-7-1 Minatojima Minamimachi, Chuo-ku, Kobe, Hyogo 650-0047 Japan; Kobe City Eye Hospital, 2-1-8 Minatojima Minamimachi, Chuo-ku, Kobe, Hyogo 650-0047 Japan. Electronic address:

View Article and Find Full Text PDF

Purpose: Retinitis pigmentosa represents a leading cause of blindness in developed countries, yet effective treatments for the disease remain unestablished. Previous studies have demonstrated the potential of stem cell-derived retinal organoid (SC-RO) sheet transplantation to form host-graft synapses and to improve light responsiveness in animal models of retinal degeneration. However, the detailed microstructures of these de novo synapses and their functional contribution have not been well elucidated.

View Article and Find Full Text PDF

Transplantation of human pluripotent stem cell-derived retinal sheet in a primate model of macular hole.

Stem Cell Reports

November 2024

Laboratory for Retinal Regeneration, RIKEN Center for Biosystems Dynamics Research, Kobe, Hyogo 650-0047, Japan; Kobe City Eye Hospital, Kobe, Hyogo 650-0047, Japan. Electronic address:

Macular hole (MH) is a retinal break involving the fovea that causes impaired vision. Although advances in vitreoretinal surgical techniques achieve >90% MH closure rate, refractory cases still exist. For such cases, autologous retinal transplantation is an optional therapy showing good anatomic success, but visual improvement is limited and peripheral visual field defects are inevitable after graft harvesting.

View Article and Find Full Text PDF

Background: Gene editing of immunomodulating molecules is a potential transplantation strategy to control immune rejection. As we noticed the successful transplantation of retinal pigment epithelium (RPE) derived from embryonic stem cells of a cynomolgus monkey that accidentally lacked MHC class II (MHC-II) molecules, we hypothesized immune rejection could be evaded by suppressing MHC-II.

Methods: Gene editing by the Crispr/Cas9 system was performed in induced pluripotent stem cells derived from a cynomolgus monkey (miPSCs) for targeted deletion of the gene coding class II MHC trans-activator (CIITA).

View Article and Find Full Text PDF

The retinal fovea in human and nonhuman primates is essential for high acuity and color vision. Within the fovea lies specialized circuitry in which signals from a single cone photoreceptor are largely conveyed to one ON and one OFF type midget bipolar cell (MBC), which in turn connect to a single ON or OFF midget ganglion cell (MGC), respectively. Restoring foveal vision requires not only photoreceptor replacement but also appropriate reconnection with surviving ON and OFF MBCs and MGCs.

View Article and Find Full Text PDF

This study evaluates the transplantation of induced pluripotent stem cell (iPSC)-derived retinal organoids into patients with advanced retinitis pigmentosa using adaptive optics optical coherence tomography (AO-OCT) to monitor retinal changes over two years post transplantation. Our results confirmed successful engraftment and increased retinal thickness, with AO-OCT providing detailed visualization of cellular structures such as an outer plexiform layer-like line and highly reflective particles within rosette-like formations, indicative of photoreceptor development. Immunohistological analysis in a parallel monkey model confirmed these structures as mature, functional photoreceptor rosettes.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates the effectiveness of retinal pigment epithelium replacement therapy for patients with Bietti crystalline dystrophy (BCD) by examining the relationship between fundus autofluorescence abnormalities and visual field defects.
  • It includes data from 16 BCD patients and 16 patients with RHO-associated retinitis pigmentosa, analyzing their fundus autofluorescence and visual field test results.
  • Findings reveal that in BCD patients, the area of FAF abnormalities does not correlate with visual field loss, highlighting the potential for therapy to help preserve remaining vision, unlike in RHO-associated cases where correlations were stronger.
View Article and Find Full Text PDF
Article Synopsis
  • Glutamate excitotoxicity contributes to the death of retinal ganglion cells (RGCs) in conditions like glaucoma and ischemia-reperfusion injury, causing both direct and indirect damage through inflammation.
  • The study focused on Omidenepag (OMD), a new drug that lowers intraocular pressure and acts as an EP2 receptor agonist, investigating its potential neuroprotective effects against excitotoxic RGC death.
  • OMD was found to significantly reduce RGC death and inflammatory responses in both in vitro and in vivo models, suggesting it promotes protective pathways while inhibiting harmful ones by improving interactions between glial cells and neurons.
View Article and Find Full Text PDF
Article Synopsis
  • Retinitis pigmentosa (RP) is a common inherited eye disease that leads to blindness, caused by various gene variants, making genetic diagnosis crucial for treatment and prognosis.
  • This study focused on using multiplex ligation-dependent probe amplification (MLPA) to identify copy number variations (CNVs) in the EYS gene connected to RP, particularly since next-generation sequencing (NGS) has limitations in detecting CNVs.
  • Results confirmed CNVs in eight patients initially identified through NGS, and found additional CNVs in 2 out of 42 undiagnosed patients, highlighting that NGS can be effective for CNV detection in RP cases despite some limitations.
View Article and Find Full Text PDF

Inherited retinal dystrophies comprise a clinically complex and heterogenous group of diseases characterized by visual impairment due to pathogenic variants of over 300 different genes. Accurately identifying the causative gene and associated variant is crucial for the definitive diagnosis and subsequent selection of precise treatments. Consequently, well-validated genetic tests are required in the clinical practice.

View Article and Find Full Text PDF

Pigmentation level of human iPSC-derived RPE does not indicate a specific gene expression profile.

Elife

May 2024

Laboratory for Retinal Regeneration, RIKEN Biosystems Dynamics Research (BDR), Kobe, Japan.

Retinal pigment epithelium (RPE) cells show heterogeneous levels of pigmentation when cultured in vitro. To know whether their color in appearance is correlated with the function of the RPE, we analyzed the color intensities of human-induced pluripotent stem cell-derived RPE cells (iPSC-RPE) together with the gene expression profile at the single-cell level. For this purpose, we utilized our recent invention, Automated Live imaging and cell Picking System (ALPS), which enabled photographing each cell before RNA-sequencing analysis to profile the gene expression of each cell.

View Article and Find Full Text PDF
Article Synopsis
  • A global study has investigated the use of human pluripotent stem cell-derived retinal pigment epithelial cells (hiPSC-RPE) for treating diseases like age-related macular degeneration, highlighting the pros and cons of cell suspensions and sheets.
  • The hiPSC-RPE strips were created to offer a less invasive method for cell delivery, demonstrating stable survival in a cynomolgus monkey model after transplantation into both damaged and healthy retinal areas.
  • The transplanted RPE cells not only expanded more at the injury site without causing tumors but also exhibited important cellular characteristics for effective retinal therapy.
View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to clarify the genetic and clinical features of Japanese patients suffering from ABCA4-associated retinopathy by analyzing their genetic variants and eye health.
  • A total of 63 patients were analyzed, revealing diverse genetic variants associated with different phenotypes, including some showing milder symptoms and others experiencing rapid degeneration.
  • Findings suggest that specific genetic patterns, particularly truncation/truncation mutations, lead to severe retinal issues, which helps inform patient prognosis and potential clinical trial eligibility.
View Article and Find Full Text PDF

This study aimed to investigate how the extent and central/peripheral location of the residual visual field (VF) in patients with late-stage inherited retinal diseases (IRDs) are related to retinal sensitivity detected using full-field stimulus testing (FST). We reviewed the results of Goldmann perimetry and FST from the medical records of patients with IRDs whose VF represents central (within 10°) and/or peripheral islands, or undetectable. In total, 19 patients (19 eyes) were analyzed in this study.

View Article and Find Full Text PDF
Article Synopsis
  • The retinal pigment epithelium (RPE) is crucial for eye health and its dysfunction can lead to visual disorders, making hiPSC-RPE transplantation a potential therapy for conditions like age-related macular degeneration.* -
  • Gelatin hydrolysate was tested to improve hiPSC-RPE transplantation by reducing cell reflux, boosting cell viability, and decreasing inflammation, demonstrating beneficial effects on cell behavior and performance in a lab setting.* -
  • The study concludes that gelatin hydrolysate may significantly enhance the success of hiPSC-RPE therapies, making it a promising candidate for future regenerative treatments in vision-related disorders.*
View Article and Find Full Text PDF

Label-free enrichment of human pluripotent stem cell-derived early retinal progenitor cells for cell-based regenerative therapies.

Stem Cell Reports

February 2024

Laboratory for Retinal Regeneration, RIKEN Center for Biosystems Dynamics Research, Kobe, Hyogo 650-0047, Japan; Department of Ophthalmology, Kobe City Eye Hospital, Kobe, Hyogo 650-0047, Japan.

Article Synopsis
  • Pluripotent stem cell therapy shows potential in treating retinal degenerative diseases, as demonstrated in a clinical study with retinal organoid sheets for patients with retinitis pigmentosa.
  • Current challenges in the graft preparation process stem from the need for advanced techniques to extract suitable retinal progenitor cells from limited organoids.
  • A new sorting method using label-free ghost cytometry successfully enriches retinal progenitor cells, enabling the formation of transplantable retinal spheroids that develop mature photoreceptors in animal models of retinal degeneration.
View Article and Find Full Text PDF

We investigated the potential of ChatGPT in the ophthalmological field in the Japanese language using board examinations for specialists in the Japanese Ophthalmology Society. We tested GPT-3.5 and GPT-4-based ChatGPT on five sets of past board examination problems in July 2023.

View Article and Find Full Text PDF

Objective: Cystoid macular edema (CME) in retinitis pigmentosa (RP) is an important complication causing visual dysfunction. We investigated the effect of CME on photoreceptors in RP patients with previous or current CME, using an adaptive optics (AO) fundus camera.

Methods: We retrospectively observed the CME and ellipsoid zone (EZ) length (average of horizontal and vertical sections) by optical coherence tomography.

View Article and Find Full Text PDF

Safety and stable survival of stem-cell-derived retinal organoid for 2 years in patients with retinitis pigmentosa.

Cell Stem Cell

December 2023

Department of Ophthalmology, Kobe City Eye Hospital, Kobe 650-0047, Japan; Department of Ophthalmology, Kobe City Medical Center General Hospital, Kobe 650-0047, Japan; Laboratory for Retinal Regeneration, RIKEN Center for Biosystems Dynamics Research, Kobe 650-0047, Japan.

Article Synopsis
  • The study explores the transplantation of retinal organoid sheets derived from induced pluripotent stem cells (iPSCs) into patients with advanced retinitis pigmentosa, assessing both safety and survival of the transplant.
  • Results showed that the retinal organoid sheets remained stable for 2 years post-transplant and led to increased retinal thickness without serious side effects in both patients.
  • Visual function improvement was noted to be less progressive in the treated eyes compared to untreated ones, indicating that iPSC-derived retinal organoid sheet transplantation may be a promising treatment for retinal diseases that requires further investigation.
View Article and Find Full Text PDF

Purpose: Novel therapeutic options, such as regenerative medicine and gene therapy, are now emerging as viable treatment options for patients with severe visual impairments, such as retinitis pigmentosa (RP). Gradable assessment of patients' visual function is essential to consider treatment options and to evaluate treatment outcomes; however, evaluation of visual function in patients with advanced low vision is often challenging because of patients' poor and sometimes unpredictable responses. In this study, we attempted to accurately assess visual capabilities and disease stage in patients with RP with a visual acuity (VA) of ≤ 0.

View Article and Find Full Text PDF

Purpose: To describe a novel case of bilateral rapidly progressive retinopathy after immunotherapy with pembrolizumab for metastatic urothelial carcinoma.

Methods: Case report.

Results: A 64-year-old man undergoing pembrolizumab immunotherapy was referred to our hospital because of bilateral acute vision loss.

View Article and Find Full Text PDF